Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Asset Utilization Ratio (2017 - 2025)

Historic Asset Utilization Ratio for Adma Biologics (ADMA) over the last 14 years, with Q3 2025 value amounting to 0.87.

  • Adma Biologics' Asset Utilization Ratio fell 1314.59% to 0.87 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.87, marking a year-over-year decrease of 1314.59%. This contributed to the annual value of 1.04 for FY2024, which is 3683.99% up from last year.
  • Latest data reveals that Adma Biologics reported Asset Utilization Ratio of 0.87 as of Q3 2025, which was down 1314.59% from 0.89 recorded in Q2 2025.
  • Adma Biologics' Asset Utilization Ratio's 5-year high stood at 1.03 during Q2 2024, with a 5-year trough of 0.22 in Q1 2021.
  • Its 5-year average for Asset Utilization Ratio is 0.69, with a median of 0.67 in 2022.
  • As far as peak fluctuations go, Adma Biologics' Asset Utilization Ratio skyrocketed by 13957.89% in 2022, and later tumbled by 1350.22% in 2025.
  • Adma Biologics' Asset Utilization Ratio (Quarter) stood at 0.43 in 2021, then skyrocketed by 41.33% to 0.6 in 2022, then skyrocketed by 47.56% to 0.89 in 2023, then increased by 9.29% to 0.97 in 2024, then fell by 10.62% to 0.87 in 2025.
  • Its last three reported values are 0.87 in Q3 2025, 0.89 for Q2 2025, and 0.92 during Q1 2025.